These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 730927)

  • 21. The effects of three psychoactive drugs on two varieties of escape behavior.
    Appel JB; Freedman DX; Filby YM
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):179-93. PubMed ID: 6035095
    [No Abstract]   [Full Text] [Related]  

  • 22. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
    Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of alcohol-induced cortical depression with stimulants and tertiary amines.
    Greenberg RE
    Q J Stud Alcohol; 1967 Mar; 28(1):1-10. PubMed ID: 6030083
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of LSD on responses to colored photic stimuli as related to visual imagery ability in man.
    Shryne JE; Brown BB
    Proc West Pharmacol Soc; 1965; 8():42-6. PubMed ID: 5863053
    [No Abstract]   [Full Text] [Related]  

  • 26. Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.
    Moore RH; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):66-73. PubMed ID: 581833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
    Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
    Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed auditory feedback in schizophrenia and LSD-induced state.
    Vinar O; Bastecký J; Borovicková B; Zichová M; Malac V
    Act Nerv Super (Praha); 1965 Aug; 7(3):302-3. PubMed ID: 5882134
    [No Abstract]   [Full Text] [Related]  

  • 29. LSD and d-amphetamine effects on fixed interval responding in the rat.
    Ksir C; Nelson S
    Pharmacol Biochem Behav; 1977 Mar; 6(3):269-72. PubMed ID: 857253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The psychotogenic 'double-blind' model in psycholysis. Case study contribution to the sociogenic theory of schizophrenia.
    Hausner M
    Psychother Psychosom; 1975; 25(1-6):26-8. PubMed ID: 1093221
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative phenomenology of experimental mental alterations after application of LSD, benactyzine and phenmetrzine.
    Dolezal V; Hausner M
    Act Nerv Super (Praha); 1968 Oct; 10(3):280-2. PubMed ID: 5702526
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 34. Current views on the psychophysiology of hypnosis.
    Mellett P
    Br J Hosp Med; 1980 May; 23(5):441, 444-6. PubMed ID: 7388200
    [No Abstract]   [Full Text] [Related]  

  • 35. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
    Iriye TT; Kuna A; Simmonds FA
    Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600
    [No Abstract]   [Full Text] [Related]  

  • 36. Modification of the pigment screening of the frog retina following administration of neuroactive drugs.
    Kemali M; Milici N; Kemali D
    Exp Eye Res; 1983 Nov; 37(5):493-8. PubMed ID: 6142827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs and the discrimination of duration.
    Altman JL; Appel JB; McGowan WT
    Psychopharmacology (Berl); 1979 Jan; 60(2):183-8. PubMed ID: 106429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 39. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lysergic acid diethylamide (LSD-25) on impulse control.
    ARONSON H; KLEE GD
    J Nerv Ment Dis; 1960 Dec; 131():536-9. PubMed ID: 13684462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.